Answers are grounded in this paper and cite their sources.
OBJECTIVES: F]FCH PET-CT and multiparametric magnetic resonance imaging (mpMRI). METHODS: F]FCH PET-CT findings were correlated with mpMRI and histopathologic results. RESULTS: F]FCH: mean SUVmax: 6.08 ± 2.74, median: 5.5; p = 0.13). CONCLUSIONS: Ga]Ga-RM2 PET-CT and mpMRT in the high-risk group. In addition, GRP-R-based imaging seems to play a complementary role to choline-based imaging for full characterization of PCa extent and biopsy guidance in low- and intermediate-metastatic-risk PCa patients and has the potential to discriminate them from those at higher risks. KEY POINTS: Ga]Ga-RM2 is a promising PET tracer with a high detection rate for intraprostatic PCa especially in intermediate-risk prostate cancer patients. • GRPr-based imaging seems to play a complementary role to choline-based or PSMA-based PET/CT imaging in selected low- and intermediate-risk PCa patients for better characterization and eventually biopsy guidance of prostate cancer disease.
No takes yet. Share an insight, caveat, or question.
Beheshti et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: